
JAMA study reveals side effect impact of localized prostate cancer treatments
A study published in JAMA comparing adverse event outcomes by treatment type for patients with localized prostate cancer reveals most...
Moon Shot helps corner aggressive-variant prostate cancer
Prostate cancer is the most common cancer diagnosed in American men, and the second leading cause of cancer death in men. While hormone-based...
New approach enhances PD-L1 detection to aid in immunotherapy selection
Just as a driver’s night vision improves by simply cleaning the headlights, scientists at The University of Texas MD Anderson Cancer Center have discovered that removing an unwanted element from a protein known to suppress the immune system may eventually help clinicians better observe which cancer patients will benefit by treatment with immune checkpoint blockades.
Heng-Huan Lee, Ph.D., a postdoctoral fellow and Ying-Nai Wang,...

The search for valuable cancer-related proteins
MD Anderson’s proteomics platform provides a valuable institutional resource, complete with state-of-the-art instruments and specialized expertise...
Immunotherapy advances in targeting pancreatic, prostate and kidney cancers
This is the second part of Cancer Frontline’s interview with Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology...
Immunotherapy leader details ongoing expansion of cancer treatment's reach
In October 2018, the Nobel Prize in Physiology or Medicine was awarded to Jim Allison, Ph.D., chair of Immunology, for his discoveries on...
An update on the Prostate Cancer Moon Shot's efforts to improve outcomes, save lives
Excluding skin cancers, prostate cancer is the most commonly diagnosed cancer among men in the United States. According to the American Cancer...
Protein inhibits prostate cancer metastasis
Reported online in the July 28 issue of Molecular Cell, a study conducted at MD Anderson has shown that a protein called ZMYND8 blocks expression...
Aggressive prostate cancer's origins unmasked
New findings about where and how aggressive forms of prostate cancer potentially begin may lead to new therapies for hard-to-treat and lethal...